ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

24 hedge funds and large institutions have $4.98M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.13M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$83K
3
Northern Trust
3
Northern Trust
Illinois
$54K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$67K
5
Morgan Stanley
5
Morgan Stanley
New York
$47K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$269K
2
ECM
2
ExodusPoint Capital Management
New York
$0
3
Bank of America
3
Bank of America
North Carolina
$40K
4
DY
4
Dowling & Yahnke
California
$495K
5
TRCT
5
Tower Research Capital (TRC)
New York
$2K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
– – -81 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– – -63 Closed
Barclays
28
Barclays
United Kingdom
– – -10 Closed
Deutsche Bank
29
Deutsche Bank
Germany
– – -4 Closed
DAM
30
Delta Asset Management
Tennessee
$0 7 – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$0 3 +1 +50%
1
2